A simple method for assessing the strength of evidence for association at the level of the whole gene

Advances and Applications in Bioinformatics and Chemistry

Volumn 5, Issue 1, 2012, Pages 115-120

  Curtis, David ^a   Vine, Anna E ^a   Knight, Jo ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Fisher; Genetic marker; Significance

Indexed keywords

EID: 84864958219     PISSN: None     EISSN: 11786949     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Besag J, Clifford P. 1991. Sequential Monte Carlo p-values. Biometrika, 78: 301-4.
2. Chapman J, Clayton D. 2007. One degree of freedom for dominance in indirect association studies. Genet Epidemiol, 31: 261-71.
3. Chapman JM, Cooper JD, Todd JA, et al. 2003. Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered, 56: 18-31.
4. Chen BE, Sakoda LC, Hsing AW, et al. 2006. Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genet Epidemiol, 30: 495-507.
5. Clayton D, Chapman J, Cooper J. 2004. Use of unphased multilocus genotype data in indirect association studies. Genet Epidemiol, 27: 415-28.
6. Curtis D, Knight J, Sham PC. 2006. Program report: GENECOUNTING support programs. Ann Hum Genet, 70: 277-9.
7. Dudbridge F, Koeleman BP. 2004. Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies. Am J Hum Genet, 75: 424-35.
8. Fisher RA. 1925. Statistical methods for research workers, 13 ed. London: Oliver and Boyd.
9. Fung HC, Scholz S, Matarin M, et al. 2006. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol, 5: 911-6.
10. Hoh J, Wille A, Ott J. 2001. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res, 11: 2115-9.
11. Knight J, Curtis D, Sham PC. 2008. CLUMPHAP: a simple tool for performing haplotype-based association analysis. Genet Epidemiol, 32: 539-45.
12. Neale BM, Sham PC. 2004. The future of association studies: gene-based analysis and replication. Am J Hum Genet, 75: 353-62.
13. North B, Sham PC, Knight J, et al. 2006. Investigation of the ability of haplotype association and logistic regression to identify associated susceptibility loci [online]. Ann Hum Genet, 70: 893-906.
14. North BV, Curtis D, Sham PC. 2003a. A note on calculation of empirical P values from Monte Carlo procedure. Am J Hum Genet, 72: 498-9.
15. North BV, Curtis D, Cassell PG, et al. 2003b. Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes. Ann Hum Genet, 67: 348-56.
16. Potter DM. 2006. Omnibus permutation tests of the association of an ensemble of genetic markers with disease in case-control studies. Genet Epidemiol, 30: 438-46.
17. Purcell S, Neale B, Todd-Brown K, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet, 81: 559-75.
18. Strauss KM, Martins LM, Plun-Favreau H, et al. 2005. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet,14: 2099-11.
19. Wacholder S, Chanock S, Garcia-Closas M, et al. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst, 96: 434-42.
20. Yang HC, Lin CY, Fann CS. 2006. A sliding-window weighted linkage disequilibrium test. Genet Epidemiol, 30: 531-45.
21. Zaykin DV, Zhivotovsky LA, Westfall PH, et al. 2002. Truncated product method for combining P-values. Genet Epidemiol, 2002, 22: 170-85.
22. Zhao JH, Lissarrague S, Essioux L, et al. 2002. GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics, 18: 1694-5.